Endothelium-dependent vasodilation is augmented by angiotensin converting enzyme inhibitors in healthy volunteers

Journal of Cardiovascular Pharmacology

Volumn 20, Issue 6, 1992, Pages 949-954

  Nakamura, Motoyuki ^a   Funakoshi, Tsutomu ^a   Yoshida, Hiroaki ^a   Arakawa, Naoshi ^a   Suzuki, Tomoyuki ^a   Hiramori, Katsuhiko ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Acetylsalicylic acid; Angiotensin converting enzyme inhibitor; Endothelium; Endothelium derived hyperpolarzing factor; Endothelium derived relaxing factor; Forearm blood flow; Humans; NG monomethyl L arginine; Prostaglandin; Sodium nitroprusside

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ENALAPRILAT; ENDOTHELIUM DERIVED RELAXING FACTOR; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG POTENTIATION; FEMALE; FOREARM; FOREARM BLOOD FLOW; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

ACETYLCHOLINE; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARGININE; ASPIRIN; DRUG SYNERGISM; ENALAPRILAT; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMAN; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGE; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; REGIONAL BLOOD FLOW; SUPPORT, NON-U.S. GOV'T; VASCULAR RESISTANCE; VASODILATION;

EID: 0026683787     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199212000-00015     Document Type: Article

References (24)

1. Vanhoutte PM, Auch-Schwelk W, Biondi ML, Lorenz RR, Schini VB, Vidal MJ. Why are converting enzyme inhibitors vasodilators? Br J Clin Pharmacol 1989;28:95S-104.
2. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987;79:1-6.
3. Erdös EG. Angiotensin I converting enzyme. Circ Res 1975;36:247-55.
4. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 1990;16:532-40.
5. Mombouli JV, Nephtali M, Vanhoutte PM. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Hypertension 1991;18(suppl II):II-22-9.
6. Ulm EH, Hichens M, Gomez HJ, et al. Enalaprilat maleate and a lysine analogue (MK-521): disposition in man. Br J Clin Pharmacol 1982;14:357-62.
7. Benjamin N, Cockcroft JR, Collier JG, Dollery CT, Ritter JM, Webb DJ. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol (Lond) 1989;412:543-55.
8. Bank AJ, Kubo SH, Rector TS, Heifetz SM, William RE. Local forearm vasodilation with intra-arterial administration of enalaprilat in humans. Clin Pharmacol Ther 1991;50:314-21.
9. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond) 1980;288:373-6.
10. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarisation of canine coronary smooth muscle. Br J Pharmacol 1988;93:515-24.
11. Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Circulation 1990;81:1762-7.
12. Webb DJ, Collier JG. Influence of ramiprilat diacid on the peripheral vascular effects of angiotensin I. Am J Cardiol 1987;59:45D-9.
13. Lüscher TF, Vanhoutte, Disease. In: Lüscher TF, Vanhoutte, eds. The endothelium: modulator of cardiovascular function. Boca Raton: CRC Press, 1990:111-46.
14. Woodman OL, Dusting GJ, Nolan RD. Peripheral release of prostacyclin induced by bradykinin and angiotensin II: effects on coronary blood flow in the dog. J Cardiovasc Pharmacol 1983;5:954-60.
15. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release foreaccounts for the biological activity of endothelium-dependent relaxing factor. Nature (Lond) 1987;327:524-6.
16. Goldschmidt JE, Tallarida RJ. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effects of sulfhydryl groups on endothelium-derived relaxing factor. J Pharmacol Exp Ther 1991;257:1136-45.
17. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;2:997-1044.
18. Wiemer G, Schlkens BA, Becker RHA, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 1991;18:558-63.
19. Kiowski W, Linder L, Kleinbloesem C, van Brummelen P, Bühler FR. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition. Circulation 1992;85:1-8.
20. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
21. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz ST. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-96.
22. Motz W, Vogt M, Rabenau O, Scheler S, Luckhoff A, Strauer BE. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991;68:996-1003.
23. Mancini DM, Davis L, Wexler JP, Chadwick B, LeJemtel TH. Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy. J Am Coll Cardiol 1987;10:845-50.
24. Lai C, Onnis E, Orani E, Pirisi R, Soro A, Cherchi A. Effects of enalapril in normotensive patients with stable effort angina: a double blind, placebo controlled study. Drugs Exp Clin Res 1990;16:299-305.